NG

Nitin Goyal

Active Director Director DIN 09551576
DIN 09551576 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2022
Shareholding value •••• Premium profile

About Nitin Goyal

Data last updated:

Nitin Goyal is a Director at Tyscon Pharmaceuticals Private Limited (since 2022) and Director at Amicable Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹4.99 Cr; the largest is Tyscon Pharmaceuticals Private Limited at ₹3.40 Cr (FY 2025).

DIN 09551576
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2022
Oldest Company Age 8 yrs
Largest company Tyscon Pharmaceuticals Private Limited · ₹3.40 Cr (FY 2025)
Combined revenue ₹4.99 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20222018₹3.40 Cr (FY 2025)Active
Director29 Mar 20222022₹1.59 Cr (FY 2025)Active

Board colleagues of Nitin Goyal

Directorship timeline

Open interactive timeline →
Amicable Pharmaceuticals Private Limited
Tyscon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitin Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Goyal

Nitin Goyal currently holds 2 directorships: Tyscon Pharmaceuticals Private Limited (Director, since 09 Aug 2022, revenue ₹3.40 Cr (FY 2025)); Amicable Pharmaceuticals Private Limited (Director, since 29 Mar 2022, revenue ₹1.59 Cr (FY 2025)).

Nitin Goyal was first appointed on 29 Mar 2022 as Director at Amicable Pharmaceuticals Private Limited.

The 2 current companies of Nitin Goyal that report revenue have a combined latest revenue of ₹4.99 Cr: Tyscon Pharmaceuticals Private Limited ₹3.40 Cr (FY 2025); Amicable Pharmaceuticals Private Limited ₹1.59 Cr (FY 2025).

The current boards of Nitin Goyal's companies include Deepak Goyal (Tyscon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available